Top 5 Dermatology Articles of 2024

News
Article

This year’s top dermatology posts on Managed Healthcare Executive include stories about Gen Z sunscreen trends and increasing incidences of ringworm and jock itch.

1. Highly Contagious and Hard-to-Treat Fungal Skin Infections Are Emerging, Experts Warn

Experts are urging healthcare providers to be aware of these two new forms of ringworm or jock itch, known as Trichophyton mentagrophytes type VII (TMVII) and Trichophyton indotineae or T. indotineae.

Read here

2. High Sodium Intake Associated to Increased Risk of Severe Atopic Dermatitis

Researchers who conducted the study, of the Universities of California in San Francisco and Berkley, suggest that cutting down on sodium could be a more cost-effective and low-risk way to help manage AD.

Read here

3. Gen Z’s Passion for Skincare Falls Short on Sun Protection, AAD Study Finds

In a recent American Academy of Dermatology survey, it was revealed that 52% of Gen Z adults ages 18 to 26 are unaware of key sunburn risks, such as increased skin cancer risk and premature aging.

Read here

4. Study Examines the Correlation Between COVID-19 Vaccination and Vitiligo Onset

A recent study presents a unique case of sudden-onset vitiligo following the COVID-19 vaccination, along with a systematic review of existing literature to shed light on the potential link between vaccination and vitiligo development.

Read here

5. Vtama Is Getting Ready to Elbow Its Way Into the Crowded Field of Atopic Dermatitis Medications

The FDA approved Dermavant Science's Vtama (tapinarof cream) last year as a treatment for plaque psoriasis. Sales have been disappointing, according to press reports. Will Vtama, which has a different mechanism of action than the current batch of topical medications for atopic dermatitis, fare better in the atopic dermatitis market?

Read here

Recent Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 Kol is featured in this series
1 Kol is featured in this series
Related Content
© 2024 MJH Life Sciences

All rights reserved.